Green Thumb Industries (GTBIF) Change in Accured Expenses (2019 - 2026)
Green Thumb Industries' (GTBIF) quarterly Change in Accured Expenses came in at -$4.1 million in Q1 2026, down 237.58% YoY from $3.0 million in Q1 2025, and down 133.38% on a QoQ basis from $12.2 million in Q4 2025.
Green Thumb Industries (GTBIF) Change in Accured Expenses (2019 - 2026) Analysis & Trends
Green Thumb Industries (GTBIF) has 8 years of Change in Accured Expenses data on file, last reported at -$4.1 million in Q1 2026.
- Quarterly Change in Accured Expenses fell 237.58% year-over-year to -$4.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.1 million (down 56.77% YoY) and the FY2025 annual result came in at $12.1 million, down 26.52% from the prior year.
- Change in Accured Expenses slipped to -$4.1 million in Q1 2026, from $12.2 million in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $19.7 million in Q3 2024 to a low of -$20.9 million in Q2 2025.
- A 5-year average of $1.8 million and a median of $687000.0 in 2023 frame the typical range for Change in Accured Expenses.
- Annual changes were most pronounced in 2022 — Change in Accured Expenses tumbled 556.83% — and 2024, when it soared 2762.88%.
- Tracing GTBIF's Change in Accured Expenses over 5 years: stood at $6.4 million in 2022, then slumped by 116.84% to -$1.1 million in 2023, then advanced by 6.56% to -$1.0 million in 2024, then surged by 1307.21% to $12.2 million in 2025, then slumped by 133.38% to -$4.1 million in 2026.
- The last three Change in Accured Expenses figures came in at -$4.1 million (Q1 2026), $12.2 million (Q4 2025), and $17.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 82.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 142.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -219.00 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -4.00 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -8.50 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Green Thumb Industries | 1.65 Bn | 1.37 Bn | 137.87 Mn | -10.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -10.06 Mn |
| Jun 30, 2026 | -10.06 Mn |
| Mar 31, 2026 | -4.08 Mn |
| Mar 31, 2026 | -4.08 Mn |
| Dec 31, 2025 | 12.22 Mn |
| Dec 31, 2025 | 12.22 Mn |
| Sep 30, 2025 | 17.80 Mn |
| Sep 30, 2025 | 17.80 Mn |
| Jun 30, 2025 | -20.87 Mn |
| Jun 30, 2025 | -20.87 Mn |
| Mar 31, 2025 | 2.96 Mn |
| Mar 31, 2025 | 2.96 Mn |
| Dec 31, 2024 | -1.01 Mn |
| Dec 31, 2024 | -1.01 Mn |
| Sep 30, 2024 | 19.67 Mn |
| Sep 30, 2024 | 19.67 Mn |
| Jun 30, 2024 | -9.88 Mn |
| Jun 30, 2024 | -9.88 Mn |
| Mar 31, 2024 | 7.71 Mn |
| Mar 31, 2024 | 7.71 Mn |